Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1
Biochemistry · 2025
DOI: 10.1021/acs.biochem.5c00105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2025. Verfasst von Daniel P Groom und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, United States. Hauptthemen laut MEDLINE: ADP Ribose Transferases. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, United States.
ORCID-Profile: Daniel P Groom, Vern L Schramm
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- Division of Cancer Prevention, National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Groom, D. P., Lopacinski, A., Garforth, S. J., & Schramm, V. L. (2025). Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1. Biochemistry. https://doi.org/10.1021/acs.biochem.5c00105
Vancouver
Groom DP, Lopacinski A, Garforth SJ, Schramm VL. Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1. Biochemistry. 2025. doi:10.1021/acs.biochem.5c00105
BibTeX
@article{Groom2025,
author = {Groom, Daniel P and Lopacinski, Amanda and Garforth, Scott J and Schramm, Vern L},
title = {Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1},
journal = {Biochemistry},
year = {2025},
doi = {10.1021/acs.biochem.5c00105}
}
EUVIMED